None
EN
Test Your Knowledge on Management of Primary Aldosteronism
['Paul Basilio', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width', 'Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar', 'Vertical-Align Middle .Wp-Block-Co-Authors-Plus-Avatar Is .Alignleft .Alignright']
Endocrinology Advisor
The Endocrine Society recently published a clinical practice guideline regarding the management of primary aldosteronism.
Test Your Knowledge Question 1 Treatment with mineralocorticoid receptor antagonists (MRAs) is preferable to nonspecific antihypertensive therapy among which type of patient with hypertension and primary aldosteronism (PA)?
Your Answer: CORRECT INCORRECT Explanation: Both answers are correct.
The GDP noted that aldosterone suppression is not required prior to initiation of PA-specific therapy for the other situations.
Your Answer: CORRECT INCORRECT Explanation: All of the answers are correct.
['correct'
'knowledge'
'test'
'question'
'aldosteronism'
'primary'
'suppression'
'management'
'true'
'answer'
'pa'
'answers'
'therapy'
'aldosterone'
'patient']